German Biotech MorphoSys Seeks Nasdaq Listing

By Sam | March 22, 2018

MorphoSys, a Germany-based biopharmaceutical company, is aiming for a listing on the Nasdaq exchange hoping to secure approximately $150 million.
Source: BioSpace

Posted in BioPharma